How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...

Learn how you can make money from the wave of seasoned companies innovating in AI and new AI tech companies. Learn about how to invest in ChatGPT, the AI chatbot dominating the internet. 5 Best AI ...